BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 22955980)

  • 1. Widespread plasticity in CTCF occupancy linked to DNA methylation.
    Wang H; Maurano MT; Qu H; Varley KE; Gertz J; Pauli F; Lee K; Canfield T; Weaver M; Sandstrom R; Thurman RE; Kaul R; Myers RM; Stamatoyannopoulos JA
    Genome Res; 2012 Sep; 22(9):1680-8. PubMed ID: 22955980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
    Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells.
    Steiner LA; Schulz V; Makismova Y; Lezon-Geyda K; Gallagher PG
    PLoS One; 2016; 11(5):e0155378. PubMed ID: 27219007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleosome repositioning links DNA (de)methylation and differential CTCF binding during stem cell development.
    Teif VB; Beshnova DA; Vainshtein Y; Marth C; Mallm JP; Höfer T; Rippe K
    Genome Res; 2014 Aug; 24(8):1285-95. PubMed ID: 24812327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTCF loss mediates unique DNA hypermethylation landscapes in human cancers.
    Damaschke NA; Gawdzik J; Avilla M; Yang B; Svaren J; Roopra A; Luo JH; Yu YP; Keles S; Jarrard DF
    Clin Epigenetics; 2020 Jun; 12(1):80. PubMed ID: 32503656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A.
    Chang JW; Hsu HS; Ni HJ; Chuang CT; Hsiung CH; Huang TH; Wang YC
    PLoS One; 2010 Sep; 5(9):e12847. PubMed ID: 20877461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity.
    Salamon D; Banati F; Koroknai A; Ravasz M; Szenthe K; Bathori Z; Bakos A; Niller HH; Wolf H; Minarovits J
    J Gen Virol; 2009 May; 90(Pt 5):1183-1189. PubMed ID: 19264589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA strand asymmetry generated by CpG hemimethylation has opposing effects on CTCF binding.
    Thomas SL; Xu TH; Carpenter BL; Pierce SE; Dickson BM; Liu M; Liang G; Jones PA
    Nucleic Acids Res; 2023 Jul; 51(12):5997-6005. PubMed ID: 37094063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.
    Dávalos-Salas M; Furlan-Magaril M; González-Buendía E; Valdes-Quezada C; Ayala-Ortega E; Recillas-Targa F
    BMC Cancer; 2011 Jun; 11():232. PubMed ID: 21663659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread site-dependent buffering of human regulatory polymorphism.
    Maurano MT; Wang H; Kutyavin T; Stamatoyannopoulos JA
    PLoS Genet; 2012; 8(3):e1002599. PubMed ID: 22457641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell differentiation is associated with reprogramming the CCCTC binding factor-dependent chromatin architecture of the murine MHC class II locus.
    Majumder P; Scharer CD; Choi NM; Boss JM
    J Immunol; 2014 Apr; 192(8):3925-35. PubMed ID: 24634495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance.
    Pant V; Kurukuti S; Pugacheva E; Shamsuddin S; Mariano P; Renkawitz R; Klenova E; Lobanenkov V; Ohlsson R
    Mol Cell Biol; 2004 Apr; 24(8):3497-504. PubMed ID: 15060168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression.
    Kang JY; Song SH; Yun J; Jeon MS; Kim HP; Han SW; Kim TY
    Oncogene; 2015 Nov; 34(45):5677-84. PubMed ID: 25703332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTCF: master weaver of the genome.
    Phillips JE; Corces VG
    Cell; 2009 Jun; 137(7):1194-211. PubMed ID: 19563753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTCF binding site classes exhibit distinct evolutionary, genomic, epigenomic and transcriptomic features.
    Essien K; Vigneau S; Apreleva S; Singh LN; Bartolomei MS; Hannenhalli S
    Genome Biol; 2009; 10(11):R131. PubMed ID: 19922652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dynamic CTCF chromatin binding landscape promotes DNA hydroxymethylation and transcriptional induction of adipocyte differentiation.
    Dubois-Chevalier J; Oger F; Dehondt H; Firmin FF; Gheeraert C; Staels B; Lefebvre P; Eeckhoute J
    Nucleic Acids Res; 2014; 42(17):10943-59. PubMed ID: 25183525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells.
    Degner SC; Verma-Gaur J; Wong TP; Bossen C; Iverson GM; Torkamani A; Vettermann C; Lin YC; Ju Z; Schulz D; Murre CS; Birshtein BK; Schork NJ; Schlissel MS; Riblet R; Murre C; Feeney AJ
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9566-71. PubMed ID: 21606361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
    Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
    PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human enhancer blocker CTC-binding factor interacts with the transcription factor Kaiso.
    Defossez PA; Kelly KF; Filion GJ; Pérez-Torrado R; Magdinier F; Menoni H; Nordgaard CL; Daniel JM; Gilson E
    J Biol Chem; 2005 Dec; 280(52):43017-23. PubMed ID: 16230345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.